Last reviewed · How we verify
NCT02412046
Quantification of the Pressure Threshold Related to Tissue Injury in Bedriden Paraplegics
NA trial testing Muscle biopsy in Pressure Ulcer in 21 participants. Terminated before completion.
2 October 2019
Quick facts
| Lead sponsor | University Hospital, Montpellier |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 21 |
| Start date | 1 October 2015 |
| Primary completion | 2 October 2019 |
| Estimated completion | 2 October 2019 |
| Sites | 1 location across France |
Drugs / interventions tested
- Muscle biopsy
Conditions studied
- Pressure Ulcer — all drugs for Pressure Ulcer →
- Bedsore — all drugs for Bedsore →
- Spinal Cord Injury — all drugs for Spinal Cord Injury →
- Paraplegia — all drugs for Paraplegia →
Sponsor
University Hospital, Montpellier
Who can join
Adults 18 to 90, any sex, with Pressure Ulcer or Bedsore. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to correlate the intensity and the duration of a mechanical strain, applied over the skin of a bedridden paraplegics, with the microvascularization parameters (oxygen saturation, blood flow and blood volume) and the early inflammatory mechanism. We want to detect the early stage of irreversible damage for each patient. To achieve this goal, we measure some specifics data over a group of 48 paraplegics admitted in the hospital for a pressure ulcer surgical treatment. The patients are randomly distributed in 4 groups. First the interface pressure between the patient body and the air mattress is recorded continuously for 3 hours (= the repositioning patient frequency): we have the pressure over each point of the patient body in contact with the mattress on this time lap. Then, we will measure the microvascularization parameters, using an O2C medical device over a trochanter on a specific anatomical area which will be thereafter biopsied. Finally, depending on the group in which they were randomly distributed, the patient will undergo a muscle biopsy on his or her trochanter at 0h, 1h, 2h or 3h after they lie down on the air mattress. This way, we will be able to determine the effect of the mechanical strain duration on the physiologic parameters. The following day, the patient is undergoing his or her surgery for removing the necrotic area of the bedsore. At the same time, we will recover some of the sample near the bedsore which would serve as a maximum inflammatory response. Then a second muscle biopsy will be performed on an innervated area to be able to determine a basal concentration of biomarkers. The inclusion period for this study will be 3 years. All the patients are followed for 24 hours then they will be followed by medical staff in their bedsore resection setting. The data gained for this study will hopefully help the scientific world to achieve a better understanding of the pressure ulcer aetiology. They will also be helpful to achieve a mobilization of the patient specific of his or her inherent characteristics with a high sensitivity level. This way we will have a more efficient bedsore prevention.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Reactive Oxygen Species and Pressure Ulcer Formation after Traumatic Injury to Spinal Cord and Brain.
Kumar S, Theis T, Tschang M, Nagaraj V, et al · · 2021 · cited 26× · PMID 34202655 · DOI 10.3390/antiox10071013
Verify or expand the search:
- PubMed search for NCT02412046
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Muscle biopsy
Trials testing the same drug.
- NCT07119749 — Vegan Whey Protein for Muscle Anabolism and Post-exercise Recovery · NA · completed
- NCT07511686 — Metabolic and Mitochondrial Changes in Statin-Induced Myopathy · completed
- NCT05456997 — Metabolic Myopathy in Endocrinopathy · terminated
- NCT05403034 — Study of the Biological Function of Muscle Satellite Cells From Patients With Obstetric Brachial Plexus Palsy · NA · completed
- NCT05394506 — Modifying Factors in Striated Muscle Laminopathies · NA · recruiting
Other recruiting trials for Pressure Ulcer
Currently open trials in the same condition.
- NCT07255937 — PMCF Study of Debridement Pad · NA · recruiting
- NCT06457555 — Knowledge Levels and Experiences of Intensive Care Nurses on the Prevention of Pressure Sores: Mixed Method · active not recruiting
- NCT06465225 — Prevention of Pressure Ulcers in Patients at Medium to High Risk of Pressure Ulcers Using the R'GO SOINS Overlay Mattres · recruiting
- NCT06438042 — Prevention of Pressure Ulcers in Patients at High Risk of Developping Pressure Ulcers Using the Low-pressure Motorized A · recruiting
- NCT06330506 — The Effect of Pressure Ulcer Care Package on the Risk of Pressure Ulcer Development · NA · recruiting
Other University Hospital, Montpellier trials
Trials by the same sponsor.
- NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
- NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
- NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
- NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
- NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02412046 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
- Last refreshed: 23 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02412046.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing